COMMUNIQUÉS West-GlobeNewswire

Shire plc : Director/PDMR Shareholding

05/03/2018 - 17:25

Director/PDMR Shareholding March 5, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Asthma Adherence Management Findings Utilizing Adherium’s Smartinhaler™ Technology Presented at AAAAI/WAO

05/03/2018 - 17:16

SAN MATEO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), announced the presentation of new study results utilizing the Smartinhaler TM technology at the Joint Congress of the American Academy of Allergy [...]

Ossur Hf : Össur hf. initiates a new share buyback program

05/03/2018 - 17:05

Announcement from Össur hf. No. 16/2018 Reykjavík, 5 March 2018 Össur hf. has decided to initiate a new share buyback program (the "Program") tomorrow, 6 March 2018, which will replace the share buyback program that was [...]

Ossur Hf : Share buyback program completed

05/03/2018 - 17:00

Announcement from Össur hf. No. 15/2018 Reykjavík, 5 March 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program was to [...]

Shire plc : U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation

05/03/2018 - 17:00

U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation NDA acceptance of prucalopride reinforces Shire's long-standing heritage in gastrointestinal (GI) conditions and deep [...]

The Alliance for Regenerative Medicine Releases 2017 Annual Data Report, Highlighting Sector Trends and Metrics

05/03/2018 - 16:43

WASHINGTON, D.C., March 05, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today announced the release of its 2017 Annual Data Report, offering an in-depth look at trends and metrics for the cell [...]

Tetra Bio-Pharma Announces Closing of Bought Deal Financing

05/03/2018 - 16:24

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OTTAWA, March 05, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Corporation ”) (TSX-V: TBP ) (OTCQB: [...]

U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation

05/03/2018 - 16:23

U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation NDA acceptance of prucalopride reinforces Shire's long-standing heritage in gastrointestinal (GI) conditions and deep [...]

Celsion Announces Ovarian Cancer Expert Presentation at Oppenheimer & Co. Investor Event

05/03/2018 - 16:15

LAWRENCEVILLE, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) today announced that Premal H. Thaker, M.D., M.S., Associate Professor of Obstetrics and Gynecology at the Siteman Cancer Center [...]

Transactions under Novozymes’ stock buyback program

05/03/2018 - 16:13

Please read the full announcement in the attached PDF 2018_06_Stock_Buybackprogram_EN

Sharecare Introduces New Unified, Cloud-Based Platform for Medical Record Retrieval Services

05/03/2018 - 16:05

ATLANTA and LAS VEGAS, March 05, 2018 (GLOBE NEWSWIRE) -- Sharecare , the digital health company that helps people manage all their health in one place, today announced at HIMSS18 that its affiliate Sharecare Health [...]

ViewPoint Therapeutics Raises $35 Million in Series B Financing

05/03/2018 - 16:00

-- Proceeds will advance lead product candidate through clinical proof-of-concept studies in cataracts and presbyopia -- -- Series B led by The Rise Fund, a global impact fund -- SAN FRANCISCO, March 05, 2018 (GLOBE [...]

Share buy-back week 9/2018

05/03/2018 - 15:55

Announcement 5 March 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

Allakos Highlights Data Demonstrating Potential of AK002 to Rapidly Deplete Eosinophils at 2018 AAAAI/WAO Joint Congress

05/03/2018 - 15:45

-- Phase 1 data demonstrate AK002 rapidly depletes blood eosinophils after a single dose -- -- AK002 may provide an important new option in treating chronic allergic and inflammatory diseases such as eosinophilic [...]

Andrew Read to Join Board of Directors of International Endeavors Corporation

05/03/2018 - 15:30

TEMECULA, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--- International Endeavors Corporation, a Medical Marijuana IP Holdings Company today announced that Andrew Read has agreed to join the company’s [...]

Aquinox Pharmaceuticals to Announce Year End 2017 Financial Results

05/03/2018 - 15:15

VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]

Oregon Proves To Be Burgeoning Success for Advantis Corp.

05/03/2018 - 15:15

SEATTLE, WA, March 05, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) reported that their partners in Oregon just logged an order for almost fifteen times their original order, and may soon double that [...]

Predictive Technology Group, Inc.’s (PRED) Subsidiary Provides a Sponsorship at 4th Annual Perinatal Stem Cell Society Congress

05/03/2018 - 15:15

SALT LAKE CITY, March 05, 2018 (GLOBE NEWSWIRE) -- Predictive Biotech, Inc., a wholly owned subsidiary of Predictive Technology Group, Inc. (OTCPINK:PRED) provided a sponsorship at the 4 th Annual Perinatal Stem Cell [...]

Obalon Schedules Fourth Quarter and Year End 2017 Financial Results Conference Call for March 5, 2018 at 5:00 p.m. Eastern Time

05/03/2018 - 15:01

SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]